Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 EUR | -1.75% | -0.59% | -36.84% |
04-08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-25 | Advicenne: ODD designation in cystinuria | CF |
Business Summary
At the end of 2023, the group had one product in clinical development phase: ADV7103 for the treatment of distal renal tubular acidosis and for the treatment of cystinuria.
Number of employees: 21
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -12.32% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
European Union
95.7
%
| 3 | 97.5 % | 2 | 95.7 % | -13.91% |
Rest of the World
4.3
%
| 0 | 2.5 % | 0 | 4.3 % | +49.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Didier Laurens
CEO | Chief Executive Officer | 59 | 02/05/21 |
Chief Tech/Sci/R&D Officer | - | 31/03/23 | |
André Ulmann
BRD | Director/Board Member | - | 22/06/17 |
Corporate Officer/Principal | - | 30/06/21 | |
Nathalie Lemarié
LAW | General Counsel | - | 27/09/12 |
Corporate Officer/Principal | - | 31/12/07 | |
Hege Hellstrom
PRN | Corporate Officer/Principal | 59 | 25/05/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 28/04/11 | |
Catherine Dunand
BRD | Director/Board Member | 62 | 08/03/17 |
Didier Laurens
CEO | Chief Executive Officer | 59 | 02/05/21 |
Thibaut Roulon
BRD | Director/Board Member | - | 28/04/11 |
André Ulmann
BRD | Director/Board Member | - | 22/06/17 |
Charlotte Sibley
BRD | Director/Board Member | 77 | 19/09/18 |
Hege Hellstrom
PRN | Corporate Officer/Principal | 59 | 25/05/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,446,961 | 10,980,696 ( 88.22 %) | 28,884 ( 0.2321 %) | 88.22 % |
Company contact information
Sector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.84% | 22.03M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- ALDVI Stock
- Company Advicenne